You can check your eligibility by answering the questionnaire here
Based on the results, ten Kulve and colleagues (2015) argue that endogenous GLP-1 is involved in satiating effects after meal intake in obese patients with T2D (ten Kulve et al
You'll want to bring the medication in the box with your prescription (name, date of birth, etc.) sticker on it
GLP-1 analog use is associated with improved disease course in inflammatory bowel disease: a report from the Epi-IIRN
For visceral-fat-focused research where the GH-axis mechanism complements incretin-mediated effects
It has been proven that single NG neurons express multiple receptors for anorectic substances, for example GLP-1R, cholecystokinin A receptor, and leptin receptor 7,29 , but it remains unclear whether orexigenic GHSR coexists with anorectic receptors